Cargando…

Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial

BACKGROUND: Treatment of patients with recurrent glioma includes neurosurgical resection, chemotherapy, or radiation therapy. In most cases, a full course of radiotherapy has been applied after primary diagnosis, therefore application of re-irradiation has to be applied cauteously. With modern preci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Combs, Stephanie E, Burkholder, Iris, Edler, Lutz, Rieken, Stefan, Habermehl, Daniel, Jäkel, Oliver, Haberer, Thomas, Haselmann, Renate, Unterberg, Andreas, Wick, Wolfgang, Debus, Jürgen
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958944/ https://www.ncbi.nlm.nih.gov/pubmed/20925951 http://dx.doi.org/10.1186/1471-2407-10-533

Ejemplares similares

Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial
por: Combs, Stephanie E, et al.
Publicado: (2011)

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
por: Harrabi, Semi B, et al.
Publicado: (2014)

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol
por: Combs, Stephanie E, et al.
Publicado: (2006)

Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts
por: Rieken, Stefan, et al.
Publicado: (2012)

Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT)
por: Combs, Stephanie E, et al.
Publicado: (2006)

Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial
por: Combs, Stephanie E, et al.
Publicado: (2013)

In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells
por: Combs, Stephanie E, et al.
Publicado: (2012)

Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma
por: Combs, Stephanie E, et al.
Publicado: (2007)

Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas
por: Kosaki, Katsura, et al.
Publicado: (2012)

Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy
por: Habermehl, Daniel, et al.
Publicado: (2013)

Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma
por: El Shafie, Rami A., et al.
Publicado: (2018)

In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines
por: El Shafie, Rami A., et al.
Publicado: (2013)

Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma
por: Hauswald, Henrik, et al.
Publicado: (2012)

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
por: Guckenberger, Matthias, et al.
Publicado: (2020)

Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
por: Habermehl, Daniel, et al.
Publicado: (2015)

Stability of spinal bone metastases in breast cancer after radiotherapy: A retrospective analysis of 157 cases
por: Schlampp, Ingmar, et al.
Publicado: (2014)

Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma
por: Harrabi, S. B., et al.
Publicado: (2016)

Doses, fractionations, constraints for stereotactic radiotherapy
por: Borghesi, Simona, et al.
Publicado: (2022)

Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
por: Blattmann, Claudia, et al.
Publicado: (2010)

Stereotactic radiotherapy of brain metastases: clinical impact of three-dimensional SPACE imaging for 3T-MRI-based treatment planning
por: Welzel, Thomas, et al.
Publicado: (2022)

Targeting α(ν)β(3 )and α(ν)β(5 )inhibits photon-induced hypermigration of malignant glioma cells
por: Rieken, Stefan, et al.
Publicado: (2011)

Prior surgical intervention and tumor size impact clinical outcome after precision radiotherapy for the treatment of optic nerve sheath meningiomas (ONSM)
por: Adeberg, Sebastian, et al.
Publicado: (2011)

Effectiveness and Toxicity of Fractionated Proton Beam Radiotherapy for Cranial Nerve Schwannoma Unsuitable for Stereotactic Radiosurgery
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas
por: Elhateer, H., et al.
Publicado: (2008)

Fractionated stereotactic radiotherapy for pediatric patients with retinoblastoma
por: Higgins, Patrick D., et al.
Publicado: (2006)

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2017)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Impact of (18)F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy
por: Debus, Charlotte, et al.
Publicado: (2018)

Still the Cinderella
Publicado: (1961)

Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial
por: Combs, Stephanie E, et al.
Publicado: (2012)

Re-irradiation with hypo-fractionated stereotactic robotic radiotherapy for salvage in adult patients with brainstem glioma
por: Susheela, Sridhar P, et al.
Publicado: (2013)

Does Combined Fractionated Stereotactic Radiotherapy and Immunotherapy Change the Outcome of Recurrent High-Grade Gliomas?
por: Yuce Sari, Sezin, et al.
Publicado: (2021)

Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma
por: Akbaba, Sati, et al.
Publicado: (2018)

Evaluation of the tumor movement and the reproducibility of two different immobilization setups for image-guided stereotactic body radiotherapy of liver tumors
por: Dreher, Constantin, et al.
Publicado: (2018)

Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) – the ESMERALDA trial
por: Habermehl, Daniel, et al.
Publicado: (2015)

Stereotactic radiotherapy of the prostate: fractionation and utilization in the United States
por: P. Weiner, Joseph, et al.
Publicado: (2017)

Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy
por: Burgess, Laura, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j1k2c7n778ggo2csr28lea4b04